Akums Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1,522.00 Cr
as on 16-06-2024
- Paid Up Capital ₹ 5.00 Cr
as on 16-06-2024
- Company Age 28 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 4,588.67 Cr
as on 16-06-2024
- Revenue 59.89%
(FY 2023)
- Profit -206.70%
(FY 2023)
- Ebitda -310.38%
(FY 2023)
- Net Worth -827.59%
(FY 2023)
- Total Assets 3.48%
(FY 2023)
About Akums Lifesciences
- CIN/LLPIN
U24231CH1996PLC017755
- Company No.
017755
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
22 Feb 1996
- Date of AGM
18 Jun 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Akums Lifesciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rama Shanker | CFO | 02-Mar-2020 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Himanshu Saxena  | Whole-Time Director | 13-Feb-2023 | Current |
| Dharamvir Malik | Director | 31-Mar-2021 | Current |
| Rama Shanker | Director | 31-Mar-2021 | Current |
Financial Performance and Corporate Structure Insights of Akums Lifesciences.
Akums Lifesciences Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 59.89% increase. The company also saw a substantial fall in profitability, with a 206.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 827.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Akums Lifesciences?
In 2023, Akums Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Sbicap Trustee Company Limited Creation Date: 23 Apr 2013 | ₹943.75 Cr | Satisfied |
Sbicap Trustee Company Limited Creation Date: 23 Apr 2013 | ₹943.75 Cr | Satisfied |
Others Creation Date: 17 Aug 2012 | ₹15.00 Cr | Satisfied |
How Many Employees Work at Akums Lifesciences?
Akums Lifesciences has a workforce of 412 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Akums Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Akums Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
